Cargando…

Acute interstitial nephritis in the south of Iran; an observational study

BACKGROUND: Acute interstitial nephritis (AIN) is an emerging cause of acute kidney injury (AKI) during the recent years. OBJECTIVES: There is no data about prevalence, causes, clinical manifestation and outcomes of AIN in our region. Hence, in this study we aimed to find the prevalence of AIN and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Khodamoradi, Zohre, Pakfetrat, Maryam, Torabinezhad, Simin, Sagheb, Mohammad Mahdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Diabetic Nephropathy Prevention 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607987/
https://www.ncbi.nlm.nih.gov/pubmed/28975105
http://dx.doi.org/10.15171/jnp.2017.37
_version_ 1783265370071629824
author Khodamoradi, Zohre
Pakfetrat, Maryam
Torabinezhad, Simin
Sagheb, Mohammad Mahdi
author_facet Khodamoradi, Zohre
Pakfetrat, Maryam
Torabinezhad, Simin
Sagheb, Mohammad Mahdi
author_sort Khodamoradi, Zohre
collection PubMed
description BACKGROUND: Acute interstitial nephritis (AIN) is an emerging cause of acute kidney injury (AKI) during the recent years. OBJECTIVES: There is no data about prevalence, causes, clinical manifestation and outcomes of AIN in our region. Hence, in this study we aimed to find the prevalence of AIN and describe the causes, clinical presentation, and the outcome of AIN in the native kidney biopsies. PATIENTS AND METHODS: We reviewed 934 native kidney biopsies from 2006 to 2014 and collected the data of patients with the diagnosis of AIN including medical history, clinical findings, para-clinical data, pathologic findings, treatment and outcomes. RESULTS: Prevalence of AIN in our center during 2006 to 2014 was 2.5% of all renal biopsies. The common cause of AIN in our study was drugs. Of those patients admitted to hospital due to AIN, 17 patients (70.8%) received corticosteroid, five of them (29.4%) received pulse of corticosteroid, and 12 patients (70.6%) received oral drug. Around, 54.2% of the patients had hemodialysis during admission. Eight patients had received both dialysis and corticosteroid. Two of them (8.3%) remained on dialysis and 8 (33.3%) developed chronic kidney disease, but 14 (58.3%) patients recovered. CONCLUSIONS: The prevalence of AIN in our study is comparable to other studies and we found the great impact of medications on development of AIN.
format Online
Article
Text
id pubmed-5607987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Society of Diabetic Nephropathy Prevention
record_format MEDLINE/PubMed
spelling pubmed-56079872017-10-03 Acute interstitial nephritis in the south of Iran; an observational study Khodamoradi, Zohre Pakfetrat, Maryam Torabinezhad, Simin Sagheb, Mohammad Mahdi J Nephropathol Original Article BACKGROUND: Acute interstitial nephritis (AIN) is an emerging cause of acute kidney injury (AKI) during the recent years. OBJECTIVES: There is no data about prevalence, causes, clinical manifestation and outcomes of AIN in our region. Hence, in this study we aimed to find the prevalence of AIN and describe the causes, clinical presentation, and the outcome of AIN in the native kidney biopsies. PATIENTS AND METHODS: We reviewed 934 native kidney biopsies from 2006 to 2014 and collected the data of patients with the diagnosis of AIN including medical history, clinical findings, para-clinical data, pathologic findings, treatment and outcomes. RESULTS: Prevalence of AIN in our center during 2006 to 2014 was 2.5% of all renal biopsies. The common cause of AIN in our study was drugs. Of those patients admitted to hospital due to AIN, 17 patients (70.8%) received corticosteroid, five of them (29.4%) received pulse of corticosteroid, and 12 patients (70.6%) received oral drug. Around, 54.2% of the patients had hemodialysis during admission. Eight patients had received both dialysis and corticosteroid. Two of them (8.3%) remained on dialysis and 8 (33.3%) developed chronic kidney disease, but 14 (58.3%) patients recovered. CONCLUSIONS: The prevalence of AIN in our study is comparable to other studies and we found the great impact of medications on development of AIN. Society of Diabetic Nephropathy Prevention 2017-07 2017-04-20 /pmc/articles/PMC5607987/ /pubmed/28975105 http://dx.doi.org/10.15171/jnp.2017.37 Text en © 2017 The Author(s) Published by Society of Diabetic Nephropathy Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Khodamoradi, Zohre
Pakfetrat, Maryam
Torabinezhad, Simin
Sagheb, Mohammad Mahdi
Acute interstitial nephritis in the south of Iran; an observational study
title Acute interstitial nephritis in the south of Iran; an observational study
title_full Acute interstitial nephritis in the south of Iran; an observational study
title_fullStr Acute interstitial nephritis in the south of Iran; an observational study
title_full_unstemmed Acute interstitial nephritis in the south of Iran; an observational study
title_short Acute interstitial nephritis in the south of Iran; an observational study
title_sort acute interstitial nephritis in the south of iran; an observational study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607987/
https://www.ncbi.nlm.nih.gov/pubmed/28975105
http://dx.doi.org/10.15171/jnp.2017.37
work_keys_str_mv AT khodamoradizohre acuteinterstitialnephritisinthesouthofirananobservationalstudy
AT pakfetratmaryam acuteinterstitialnephritisinthesouthofirananobservationalstudy
AT torabinezhadsimin acuteinterstitialnephritisinthesouthofirananobservationalstudy
AT saghebmohammadmahdi acuteinterstitialnephritisinthesouthofirananobservationalstudy